Search Results - "BURNELLI, Roberta"
-
1
Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
Published in Infectious agents and cancer (23-06-2020)“…EBV produces miRNAs with important functions in cancer growth, tumor invasion and host immune surveillance. The discovery of EBV miR-BARTs is recent, and most…”
Get full text
Journal Article -
2
Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocol
Published in BMJ open (29-03-2021)“…IntroductionAssessment of response to therapy in paediatric patients with Hodgkin lymphoma (HL) by 18F-fluorodeoxyglucose positron emission tomography/CT has…”
Get full text
Journal Article -
3
Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
Published in International journal of molecular sciences (22-03-2020)“…The identification of circulating proteins associated with relapse in pediatric Hodgkin lymphoma (HL) may help develop predictive biomarkers. We previously…”
Get full text
Journal Article -
4
Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
Published in HemaSphere (01-02-2020)“…The objective of this guideline is to aid clinicians in making individual salvage treatment plans for pediatric and adolescent patients with first relapse or…”
Get full text
Journal Article Book Review -
5
Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence
Published in Diagnostics (Basel) (21-05-2021)“…Exosomes and other small extracellular vesicles (EVs) are potential sources of cancer biomarkers. Plasma-derived EVs have not yet been studied in pediatric…”
Get full text
Journal Article -
6
Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
Published in Frontiers in cell and developmental biology (24-11-2022)“…Currently-available therapies for newly-diagnosed pediatric and adolescent patients with Hodgkin lymphoma result in >95% survival at 5 years. Long-term…”
Get full text
Journal Article -
7
A Score for Predicting Freedom from Progression of Children and Adolescents with Hodgkin Lymphoma
Published in Hemato (01-06-2021)“…Several studies have examined the prognostic performance of therapeutic groups (TG) and early responses to therapy on positron emission tomography/computed…”
Get full text
Journal Article -
8
Nontuberculous mycobacterial adenitis in children: Diagnostic and therapeutic management
Published in American journal of otolaryngology (01-03-2003)“…We reviewed a series of 45 patients affected by nontuberculous mycobacterial adenitis of the neck observed in the Ear, Nose, and Throat Institute of S…”
Get full text
Journal Article -
9
Pleuropulmonary blastoma in congenital cystic adenomatoid malformation: report of a case
Published in European journal of pediatric surgery (01-06-2001)“…Pulmonary blastoma is a rare malignant tumor seen in both adults and children. Approximately only 25% of cases occur in pediatric patients, many of whom…”
Get more information
Journal Article -
10
Jak2 mutation expands the thrombophilic panel in children
Published in Journal of thrombosis and haemostasis (01-10-2020)“…Cerebral sinus venous thrombosis (CSVT) is an important cause of vascular accidents in children. The diagnosis of the underlying disease allows appropriate and…”
Get full text
Journal Article -
11
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
Published in Annals of hematology (01-08-2022)“…COVID-19 has a mild clinical course with low mortality rate in general pediatric population, while variable outcomes have been described in children with…”
Get full text
Journal Article -
12
Invasive mucormycosis in children with cancer: A retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association
Published in Mycoses (01-02-2019)“…Summary Background Invasive mucormycosis is a rare but frequently fatal fungal disease. The acute and rapidly progressive evolution causes unfavourable outcome…”
Get full text
Journal Article -
13
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia
Published in British journal of haematology (01-03-2020)Get full text
Journal Article -
14
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry
Published in European journal of cancer (1990) (01-03-2019)“…Advances in paediatric oncology led to the increase in long-term survival, revealing the burden of therapy-related long-term side effects. We evaluated overall…”
Get full text
Journal Article -
15
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real‐life study
Published in Pediatric blood & cancer (01-10-2022)“…Background Brentuximab vedotin (BV) is an antibody drug‐conjugated anti‐CD30 approved for the treatment of adult classical Hodgkin's lymphoma (HL), whereas it…”
Get full text
Journal Article -
16
Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm
Published in Blood (08-12-2017)“…Gaucher disease (GD) is an autosomal recessive lysosomal storage disease characterized by the deficient activity of beta-glucocerebrosidase (GBA). GBA…”
Get full text
Journal Article -
17
Interim PET response evaluation of bulky masses in pediatric Hodgkin Lymphoma
Published in The Journal of nuclear medicine (1978) (01-05-2017)“…Objectives: 18F-FDG PET is a well-established modality for the response assessment in pediatric Hodgkin's Lymphoma (HL). In a previous study we have reported…”
Get full text
Journal Article -
18
Long‐term results of high‐dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience
Published in British journal of haematology (01-08-2015)“…Summary Imatinib mesylate (IM) is used for the management of childhood chronic myeloid leukaemia (CML). The most effective dosage of IM and its long‐term…”
Get full text
Journal Article -
19
Intermittent Imatinib Mesylate in Children with Chronic Myeloid Leukemia: Results and Outcome
Published in Blood (29-11-2018)“…Imatinib mesylate (IM) has demonstrated to be highly effective in children with chronic myeloid leukemia (CML). The main issues remain the long-term side…”
Get full text
Journal Article -
20
Prospective Evaluation of Different Methods for Volumetric Analysis on [ 18 F]FDG PET/CT in Pediatric Hodgkin Lymphoma
Published in Journal of clinical medicine (21-10-2022)“…Rationale: Therapy response evaluation by 18F-fluorodeoxyglucose PET/CT (FDG PET) has become a powerful tool for the discrimination of responders from…”
Get full text
Journal Article